Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Recent nanotechnological interventions targeting PI3K/Akt/mTOR pathway: A focus on breast cancer.

Sharma V, Sharma AK, Punj V, Priya P.

Semin Cancer Biol. 2019 Aug 10. pii: S1044-579X(19)30039-2. doi: 10.1016/j.semcancer.2019.08.005. [Epub ahead of print] Review.

PMID:
31408722
2.

Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance.

Li S, Song Y, Quach C, Guo H, Jang GB, Maazi H, Zhao S, Sands NA, Liu Q, In GK, Peng D, Yuan W, Machida K, Yu M, Akbari O, Hagiya A, Yang Y, Punj V, Tang L, Liang C.

Nat Commun. 2019 Apr 12;10(1):1693. doi: 10.1038/s41467-019-09634-8.

3.

Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer.

Kubala MH, Punj V, Placencio-Hickok VR, Fang H, Fernandez GE, Sposto R, DeClerck YA.

Cell Rep. 2018 Nov 20;25(8):2177-2191.e7. doi: 10.1016/j.celrep.2018.10.082.

4.

Publisher Correction: Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations.

Nielsen HM, Andersen CL, Westman M, Kristensen LS, Asmar F, Kruse TA, Thomassen M, Larsen TS, Skov V, Hansen LL, Bjerrum OW, Hasselbalch HC, Punj V, Grønbæk K.

Sci Rep. 2018 Nov 20;8(1):17311. doi: 10.1038/s41598-018-35596-w.

5.

Regulation of Breast Cancer-Induced Osteoclastogenesis by MacroH2A1.2 Involving EZH2-Mediated H3K27me3.

Kim J, Shin Y, Lee S, Kim M, Punj V, Lu JF, Shin H, Kim K, Ulmer TS, Koh J, Jeong D, An W.

Cell Rep. 2018 Jul 3;24(1):224-237. doi: 10.1016/j.celrep.2018.06.020.

6.

MacroH2A1.2 inhibits prostate cancer-induced osteoclastogenesis through cooperation with HP1α and H1.2.

Kim JM, Shin Y, Lee S, Kim MY, Punj V, Shin HI, Kim K, Koh JM, Jeong D, An W.

Oncogene. 2018 Oct;37(43):5749-5765. doi: 10.1038/s41388-018-0356-3. Epub 2018 Jun 20.

7.

MicroRNA profiling in MDA-MB-231 human breast cancer cell exposed to the Phaleria macrocarpa (Boerl.) fruit ethyl acetate fraction (PMEAF) through IIlumina Hi-Seq technologies and various in silico bioinformatics tools.

Kavitha N, Vijayarathna S, Shanmugapriya, Oon CE, Chen Y, Kanwar JR, Punj V, Sasidharan S.

J Ethnopharmacol. 2018 Mar 1;213:118-131. doi: 10.1016/j.jep.2017.11.009. Epub 2017 Nov 14.

PMID:
29154802
8.

Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations.

Nielsen HM, Andersen CL, Westman M, Kristensen LS, Asmar F, Kruse TA, Thomassen M, Larsen TS, Skov V, Hansen LL, Bjerrum OW, Hasselbalch HC, Punj V, Grønbæk K.

Sci Rep. 2017 Jul 28;7(1):6774. doi: 10.1038/s41598-017-07057-3. Erratum in: Sci Rep. 2018 Nov 20;8(1):17311.

9.

Genome-wide analysis suggests a differential microRNA signature associated with normal and diabetic human corneal limbus.

Kulkarni M, Leszczynska A, Wei G, Winkler MA, Tang J, Funari VA, Deng N, Liu Z, Punj V, Deng SX, Ljubimov AV, Saghizadeh M.

Sci Rep. 2017 Jun 14;7(1):3448. doi: 10.1038/s41598-017-03449-7.

10.

BMP signaling orchestrates a transcriptional network to control the fate of mesenchymal stem cells in mice.

Feng J, Jing J, Li J, Zhao H, Punj V, Zhang T, Xu J, Chai Y.

Development. 2017 Jul 15;144(14):2560-2569. doi: 10.1242/dev.150136. Epub 2017 Jun 2.

11.

JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines.

Kani K, Garri C, Tiemann K, Malihi PD, Punj V, Nguyen AL, Lee J, Hughes LD, Alvarez RM, Wood DM, Joo AY, Katz JE, Agus DB, Mallick P.

Mol Cancer Ther. 2017 Aug;16(8):1645-1657. doi: 10.1158/1535-7163.MCT-16-0564. Epub 2017 May 31.

12.

Understanding and Overcoming Barriers to Upper Limb Surgical Reconstruction After Tetraplegia: The Need for Interdisciplinary Collaboration.

Punj V, Curtin C.

Arch Phys Med Rehabil. 2016 Jun;97(6 Suppl):S81-7. doi: 10.1016/j.apmr.2015.11.022.

PMID:
27233595
13.

MMP-9 facilitates selective proteolysis of the histone H3 tail at genes necessary for proficient osteoclastogenesis.

Kim K, Punj V, Kim JM, Lee S, Ulmer TS, Lu W, Rice JC, An W.

Genes Dev. 2016 Jan 15;30(2):208-19. doi: 10.1101/gad.268714.115. Epub 2016 Jan 7.

14.

NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.

Chen CL, Uthaya Kumar DB, Punj V, Xu J, Sher L, Tahara SM, Hess S, Machida K.

Cell Metab. 2016 Jan 12;23(1):206-19. doi: 10.1016/j.cmet.2015.12.004. Epub 2015 Dec 24.

15.

Linker histone H1.2 establishes chromatin compaction and gene silencing through recognition of H3K27me3.

Kim JM, Kim K, Punj V, Liang G, Ulmer TS, Lu W, An W.

Sci Rep. 2015 Nov 19;5:16714. doi: 10.1038/srep16714.

16.

Promoter Methylation Analysis Reveals That KCNA5 Ion Channel Silencing Supports Ewing Sarcoma Cell Proliferation.

Ryland KE, Hawkins AG, Weisenberger DJ, Punj V, Borinstein SC, Laird PW, Martens JR, Lawlor ER.

Mol Cancer Res. 2016 Jan;14(1):26-34. doi: 10.1158/1541-7786.MCR-15-0343. Epub 2015 Nov 16.

17.

EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.

Ring A, Mineyev N, Zhu W, Park E, Lomas C, Punj V, Yu M, Barrak D, Forte V, Porras T, Tripathy D, Lang JE.

Oncotarget. 2015 Dec 29;6(42):44623-34. doi: 10.18632/oncotarget.5977.

18.

Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome.

Andersen CL, Nielsen HM, Kristensen LS, Søgaard A, Vikeså J, Jønson L, Nielsen FC, Hasselbalch H, Bjerrum OW, Punj V, Grønbæk K.

Oncotarget. 2015 Dec 1;6(38):40588-97. doi: 10.18632/oncotarget.5845.

19.

Brca1 Mutations Enhance Mouse Reproductive Functions by Increasing Responsiveness to Male-Derived Scent.

Liu Y, Pike MC, Wu N, Lin YG, Mucowski S, Punj V, Tang Y, Yen HY, Stanczyk FZ, Enbom E, Austria T, Widschwendter M, Maxson R, Dubeau L.

PLoS One. 2015 Oct 21;10(10):e0139013. doi: 10.1371/journal.pone.0139013. eCollection 2015.

20.

Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells.

Kim JM, Kim K, Schmidt T, Punj V, Tucker H, Rice JC, Ulmer TS, An W.

Nucleic Acids Res. 2015 Oct 15;43(18):8868-83. doi: 10.1093/nar/gkv874. Epub 2015 Sep 8.

21.

NUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer.

Siddique HR, Feldman DE, Chen CL, Punj V, Tokumitsu H, Machida K.

Hepatology. 2015 Nov;62(5):1466-79. doi: 10.1002/hep.27987. Epub 2015 Aug 28.

22.

NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation.

Xu J, Chi F, Guo T, Punj V, Lee WN, French SW, Tsukamoto H.

J Clin Invest. 2015 Apr;125(4):1579-90. doi: 10.1172/JCI76468. Epub 2015 Mar 23.

23.

Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis.

HaDuong JH, Blavier L, Baniwal SK, Frenkel B, Malvar J, Punj V, Sposto R, DeClerck YA.

Int J Cancer. 2015 Aug 15;137(4):797-809. doi: 10.1002/ijc.29465. Epub 2015 Feb 21.

24.

Nanocapsules loaded with iron-saturated bovine lactoferrin have antimicrobial therapeutic potential and maintain calcium, zinc and iron metabolism.

Gupta I, Sehgal R, Kanwar RK, Punj V, Kanwar JR.

Nanomedicine (Lond). 2015;10(8):1289-314. doi: 10.2217/nnm.14.209. Epub 2014 Dec 2.

25.

Expression profiling of circulating tumor cells in metastatic breast cancer.

Lang JE, Scott JH, Wolf DM, Novak P, Punj V, Magbanua MJ, Zhu W, Mineyev N, Haqq CM, Crothers JR, Esserman LJ, Tripathy D, van 't Veer L, Park JW.

Breast Cancer Res Treat. 2015 Jan;149(1):121-31. doi: 10.1007/s10549-014-3215-0. Epub 2014 Nov 29.

26.

Orchestration of host-pathogen interaction: relevance of iron in generation of potent anti-M. tuberculosis immunity.

Rai AK, Sharma S, Punj V.

Curr Pharm Biotechnol. 2014;15(12):1095-104. Review.

PMID:
25429656
27.

Iron chelation and drug resistance in cancer and tuberculosis.

Sharma AK, Punj V, Sharma HK.

Curr Pharm Biotechnol. 2014;15(12):1093-4. No abstract available.

PMID:
25412612
28.

Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium.

Sareen D, Saghizadeh M, Ornelas L, Winkler MA, Narwani K, Sahabian A, Funari VA, Tang J, Spurka L, Punj V, Maguen E, Rabinowitz YS, Svendsen CN, Ljubimov AV.

Stem Cells Transl Med. 2014 Sep;3(9):1002-12. doi: 10.5966/sctm.2014-0076. Epub 2014 Jul 28.

29.

A pilot genome-scale profiling of DNA methylation in sporadic pituitary macroadenomas: association with tumor invasion and histopathological subtype.

Ling C, Pease M, Shi L, Punj V, Shiroishi MS, Commins D, Weisenberger DJ, Wang K, Zada G.

PLoS One. 2014 Apr 29;9(4):e96178. doi: 10.1371/journal.pone.0096178. eCollection 2014.

30.
31.

Gene dysregulation by histone variant H2A.Z in bladder cancer.

Kim K, Punj V, Choi J, Heo K, Kim JM, Laird PW, An W.

Epigenetics Chromatin. 2013 Oct 16;6(1):34. doi: 10.1186/1756-8935-6-34.

32.

Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma.

Asmar F, Punj V, Christensen J, Pedersen MT, Pedersen A, Nielsen AB, Hother C, Ralfkiaer U, Brown P, Ralfkiaer E, Helin K, Grønbæk K.

Haematologica. 2013 Dec;98(12):1912-20. doi: 10.3324/haematol.2013.088740. Epub 2013 Jul 5.

33.

Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.

Tolani B, Gopalakrishnan R, Punj V, Matta H, Chaudhary PM.

Oncogene. 2014 May 29;33(22):2928-37. doi: 10.1038/onc.2013.242. Epub 2013 Jun 24.

34.

The effect of oxandrolone on the healing of chronic pressure ulcers in persons with spinal cord injury: a randomized trial.

Bauman WA, Spungen AM, Collins JF, Raisch DW, Ho C, Deitrick GA, Nemchausky BA, Goetz LL, Park JS, Schwartz M, Merritt JL, Jayawardena V, Sandford P, Sabharwal S, Holmes SA, Nasar F, Sasaki R, Punj V, Zachow KF, Chua WC, Thomas MD, Trincher RC.

Ann Intern Med. 2013 May 21;158(10):718-26. doi: 10.7326/0003-4819-158-10-201305210-00006.

PMID:
23689765
35.

The TBC1D15 oncoprotein controls stem cell self-renewal through destabilization of the Numb-p53 complex.

Feldman DE, Chen C, Punj V, Machida K.

PLoS One. 2013;8(2):e57312. doi: 10.1371/journal.pone.0057312. Epub 2013 Feb 27.

36.

A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma.

Punj V, Matta H, Chaudhary PM.

PLoS One. 2012;7(5):e37498. doi: 10.1371/journal.pone.0037498. Epub 2012 May 18.

37.

Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells.

Feldman DE, Chen C, Punj V, Tsukamoto H, Machida K.

Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):829-34. doi: 10.1073/pnas.1114438109. Epub 2011 Dec 29.

38.

Genome-wide sperm deoxyribonucleic acid methylation is altered in some men with abnormal chromatin packaging or poor in vitro fertilization embryogenesis.

Aston KI, Punj V, Liu L, Carrell DT.

Fertil Steril. 2012 Feb;97(2):285-92. doi: 10.1016/j.fertnstert.2011.11.008. Epub 2011 Dec 9.

PMID:
22154369
39.

Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal.

Kanwar JR, Sun X, Punj V, Sriramoju B, Mohan RR, Zhou SF, Chauhan A, Kanwar RK.

Nanomedicine. 2012 May;8(4):399-414. doi: 10.1016/j.nano.2011.08.006. Epub 2011 Sep 1. Review.

PMID:
21889479
40.

A20 is induced by Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 and blocks K13-induced nuclear factor-kappaB in a negative feedback manner.

Matta H, Gopalakrishnan R, Punj V, Yi H, Suo Y, Chaudhary PM.

J Biol Chem. 2011 Jun 17;286(24):21555-64. doi: 10.1074/jbc.M111.224048. Epub 2011 Apr 29.

41.

Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice.

Ahmad A, Groshong JS, Matta H, Schamus S, Punj V, Robinson LJ, Gill PS, Chaudhary PM.

Cancer Biol Ther. 2010 Nov 15;10(10):1033-40. doi: 10.4161/cbt.10.10.13291. Epub 2010 Nov 15.

42.

X-linked ectodermal dysplasia receptor is downregulated in breast cancer via promoter methylation.

Punj V, Matta H, Chaudhary PM.

Clin Cancer Res. 2010 Feb 15;16(4):1140-8. doi: 10.1158/1078-0432.CCR-09-2463. Epub 2010 Feb 9.

43.

Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a.

Punj V, Matta H, Schamus S, Tamewitz A, Anyang B, Chaudhary PM.

Oncogene. 2010 Mar 25;29(12):1835-44. doi: 10.1038/onc.2009.460. Epub 2009 Dec 21.

44.

Molecular and biotechnological advances in milk proteins in relation to human health.

Kanwar JR, Kanwar RK, Sun X, Punj V, Matta H, Morley SM, Parratt A, Puri M, Sehgal R.

Curr Protein Pept Sci. 2009 Aug;10(4):308-38. Review.

PMID:
19689355
46.

Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation.

Punj V, Matta H, Schamus S, Yang T, Chang Y, Chaudhary PM.

Blood. 2009 May 28;113(22):5660-8. doi: 10.1182/blood-2008-10-186403. Epub 2009 Mar 26.

47.

A nuclear role for Kaposi's sarcoma-associated herpesvirus-encoded K13 protein in gene regulation.

Matta H, Punj V, Schamus S, Mazzacurati L, Chen AM, Song R, Yang T, Chaudhary PM.

Oncogene. 2008 Sep 4;27(39):5243-53. doi: 10.1038/onc.2008.150. Epub 2008 May 12.

PMID:
18469854
48.

Coat-tether interaction in Golgi organization.

Guo Y, Punj V, Sengupta D, Linstedt AD.

Mol Biol Cell. 2008 Jul;19(7):2830-43. doi: 10.1091/mbc.E07-12-1236. Epub 2008 Apr 23.

49.
50.

K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis.

Zhao J, Punj V, Matta H, Mazzacurati L, Schamus S, Yang Y, Yang T, Hong Y, Chaudhary PM.

PLoS One. 2007 Oct 24;2(10):e1067.

Supplemental Content

Support Center